Food and Drug Administration (FDA)


The Food and Drug Administration (FDA) recently approved rennet, the first biotechnologically produced enzyme approved for use in food. Much animal biotechnology research focuses on producing transgenic livestock and poultry that will utilize feed more efficiently, grow to desired slaughter weights at an earlier age, and is resistant to a variety of diseases. Farmers stand to benefit from reduced production costs, improved efficiencies, and higher quality products. Consumers will benefit because farmers will be able to supply leaner meat and poultry produced with a decreased dependence on vaccines, drugs and insecticides. In addition, consumers may see reduced prices at the grocery store, since farmers will produce animals of the same weight as is currently produced, but in a shorter period of time with lower production costs.


    Related Conference of Food and Drug Administration (FDA)

    March 27-28, 2024

    6th International Conference on Digital Health

    London, UK
    April 24-25, 2024

    35th European Heart and Heart Failure Congress

    Paris, France
    June 21-22, 2024

    52nd Global Nursing & Healthcare Conference

    Rome, Italy
    September 09-10, 2024

    3rd Global Summit on Physiology and Metabolism of Thyroid

    Paris, France
    September 18-19, 2024

    29th International Conference on Skincare and Cosmetology

    Amsterdam, Netherlands
    September 19-20, 2024

    20th Global Biomarkers and Clinical Research Summit

    Amsterdam, Netherlands
    September 24-25, 2024

    5th Global Summit on Public Health

    Paris, France

    Food and Drug Administration (FDA) Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in